MicroPort CardioFlow Medtech Corp (MicroPort), a subsidiary of MicroPort Scientific Corp, discovers, develops and commercializes medical devices for aortic stenosis, mitral regurgitation and other heart diseases. The company offers vita flow, an aortic valve system; alwide, a balloon catheter; and alpass, an introducer set. It is investigating mitral, tricuspid, and surgical valve products, procedural accessories such as balloon catheters, expandable sheaths, embolic protection devices, and catheter sheaths. MicroPort markets its products through a network of distributors across Europe, the Americas and China. The company partnership with 4C Medical Technologies Inc and ValCare Inc to develop medical solutions. MicroPort is headquartered in Shanghai, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MicroPort CardioFlow Medtech Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- MicroPort CardioFlow Medtech Corp Company Overview
- MicroPort CardioFlow Medtech Corp Company Snapshot
- MicroPort CardioFlow Medtech Corp Pipeline Products and Ongoing Clinical Trials Overview
- MicroPort CardioFlow Medtech Corp - Pipeline Analysis Overview
- MicroPort CardioFlow Medtech Corp - Key Facts
- MicroPort CardioFlow Medtech Corp - Major Products and Services
- MicroPort CardioFlow Medtech Corp Pipeline Products by Development Stage
- MicroPort CardioFlow Medtech Corp Ongoing Clinical Trials by Trial Status
- MicroPort CardioFlow Medtech Corp Pipeline Products Overview
- Alpass Catheter Sheath II
- Alpass Catheter Sheath II Product Overview
- Alwide Balloon Catheter II
- Alwide Balloon Catheter II Product Overview
- Alwide Balloon Catheter III
- Alwide Balloon Catheter III Product Overview
- Edge To Edge Tricuspid Valve Repair Device
- Edge To Edge Tricuspid Valve Repair Device Product Overview
- Embolic Protection Device - TAVI
- Embolic Protection Device - TAVI Product Overview
- Mitral Valve Repair Device
- Mitral Valve Repair Device Product Overview
- Mitral Valve Replacement Device
- Mitral Valve Replacement Device Product Overview
- Self Developed Transcatheter Tricuspid Valve Replacement Device
- Self Developed Transcatheter Tricuspid Valve Replacement Device Product Overview
- Transcatheter Tricuspid Valve Replacement Device
- Transcatheter Tricuspid Valve Replacement Device Product Overview
- VitaFlow Balloon Expandable
- VitaFlow Balloon Expandable Product Overview
- VitaFlow III
- VitaFlow III Product Overview
- VitaFlow Liberty
- VitaFlow Liberty Product Overview
- VitaFlow Liberty Clinical Trial
- VitaFlow Novo Generation
- VitaFlow Novo Generation Product Overview
- MicroPort CardioFlow Medtech Corp - Key Competitors
- MicroPort CardioFlow Medtech Corp - Key Employees
- MicroPort CardioFlow Medtech Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- MicroPort CardioFlow Medtech Corp, Recent Developments
- May 22, 2024: MicroPort Donates Medical Devices for El Salvador’s First TAVI in a Public Hospital
- May 09, 2024: Microport Cardioflow Receives Approval For Vitaflow Liberty In The EU
- Nov 20, 2023: MicroPort CardioFlow Completes Five Pre-Market Implantations of VitaFlow Liberty in Denmark
- Sep 11, 2023: Multiple MicroPort Business Groups Make an Appearance at SOLACI-SBHCI 2023
- Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
- Aug 06, 2023: Voluntary Announcement Self-Developed TMVR System Achieved Excellent Follow-up Results in Multiple Clinical Application Cases
- Aug 06, 2023: Voluntary Announcement Self-Developed TMVR System Achieved Excellent Follow-up Results in Multiple Clinical Application Cases
- Jun 02, 2023: MicroPort Group's Multiple Business Units Participate in the European Cardiovascular Intervention Conference
- Feb 24, 2023: VitaFlow Liberty and Alwide Plus by CardioFlow Medtech obtain marketing approval in Thailand
- Aug 19, 2022: VitaFlow Liberty by CardioFlow Medtech obtains marketing approval in Colombia
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- MicroPort CardioFlow Medtech Corp Pipeline Products and Ongoing Clinical Trials Overview
- MicroPort CardioFlow Medtech Corp Pipeline Products by Equipment Type
- MicroPort CardioFlow Medtech Corp Pipeline Products by Indication
- MicroPort CardioFlow Medtech Corp Ongoing Clinical Trials by Trial Status
- MicroPort CardioFlow Medtech Corp, Key Facts
- MicroPort CardioFlow Medtech Corp, Major Products and Services
- MicroPort CardioFlow Medtech Corp Number of Pipeline Products by Development Stage
- MicroPort CardioFlow Medtech Corp Pipeline Products Summary by Development Stage
- MicroPort CardioFlow Medtech Corp Ongoing Clinical Trials by Trial Status
- MicroPort CardioFlow Medtech Corp Ongoing Clinical Trials Summary
- Alpass Catheter Sheath II - Product Status
- Alpass Catheter Sheath II - Product Description
- Alwide Balloon Catheter II - Product Status
- Alwide Balloon Catheter II - Product Description
- Alwide Balloon Catheter III - Product Status
- Alwide Balloon Catheter III - Product Description
- Edge To Edge Tricuspid Valve Repair Device - Product Status
- Edge To Edge Tricuspid Valve Repair Device - Product Description
- Embolic Protection Device - TAVI - Product Status
- Embolic Protection Device - TAVI - Product Description
- Mitral Valve Repair Device - Product Status
- Mitral Valve Repair Device - Product Description
- Mitral Valve Replacement Device - Product Status
- Mitral Valve Replacement Device - Product Description
- Self Developed Transcatheter Tricuspid Valve Replacement Device - Product Status
- Self Developed Transcatheter Tricuspid Valve Replacement Device - Product Description
- Transcatheter Tricuspid Valve Replacement Device - Product Status
- Transcatheter Tricuspid Valve Replacement Device - Product Description
- VitaFlow Balloon Expandable - Product Status
- VitaFlow Balloon Expandable - Product Description
- VitaFlow III - Product Status
- VitaFlow III - Product Description
- VitaFlow Liberty - Product Status
- VitaFlow Liberty - Product Description
- VitaFlow Liberty - Clinical Evaluation of Safety and Efficacy of Retrievable Transcatheter Aortic Valve Implantation Device for the Treatment of Severe Aortic Regurgitation: A Prospective, Multicenter Study
- VitaFlow Novo Generation - Product Status
- VitaFlow Novo Generation - Product Description
- MicroPort CardioFlow Medtech Corp, Key Employees
- MicroPort CardioFlow Medtech Corp, Subsidiaries
- Glossary
- MicroPort CardioFlow Medtech Corp Pipeline Products by Equipment Type
- MicroPort CardioFlow Medtech Corp Pipeline Products by Development Stage
- MicroPort CardioFlow Medtech Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Daiichi Sankyo Pharmaceutical (Shanghai) Co Ltd
- Venus Medtech Hangzhou Inc
- LivaNova (China) Medical Technology Co. Ltd
- LifeTech Scientific Corp
- Lepu Medical Technology (Beijing) Co Ltd
